Filter
492
Filtered Results: 492
Text search:
febrile
illness
Featured
Recommendations
75
New Publications
149
Language
Document type
No document type
288
Guidelines
107
Studies & Reports
39
Manuals
18
Fact sheets
14
Training Material
9
Situation Updates
6
Strategic & Response Plan
6
Brochures
2
Infographics
2
Resource Platforms
1
Countries / Regions
India
40
Sierra Leone
16
Liberia
15
Nigeria
14
South Africa
13
Uganda
13
Kenya
12
Global
12
Africa
9
Tanzania
9
Ethiopia
9
Rwanda
8
Philippines
7
Ghana
6
Guinea
5
Latin America and the Carribbean
5
West and Central Africa
5
Bangladesh
5
Nepal
4
Senegal
4
Congo, Democratic Republic of
4
Western and Central Europe
4
East and Southern Africa
4
Myanmar / Burma
4
Lesotho
3
Cameroon
3
Malawi
3
Zimbabwe
3
Mozambique
3
Cambodia
3
South–East Asia Region
3
Namibia
3
Zambia
3
Ukraine
2
Burkina Faso
2
USA
2
Dominican Republic
2
Germany
2
Papua New Guinea
2
Brazil
2
Mali
2
South Sudan
2
Pakistan
2
Benin
1
Gambia
1
Togo
1
Syria
1
Fiji
1
Peru
1
Mauritania
1
Asia
1
Venezuela
1
Saudi Arabia
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Mauritius
1
Eastern Europe
1
Chad
1
Botswana
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
175
Clinical Guidelines
94
Women & Child Health
40
Public Health
26
Key Resources
8
Capacity Building
7
Pharmacy & Technologies
7
Toolboxes
Ebola
51
Rapid Response
50
COVID-19
45
NTDs
21
AMR
21
Pharmacy
20
Mental Health
19
HIV
15
Zika
12
Caregiver
9
TB
8
Planetary Health
6
Refugee
5
Disability
3
NCDs
2
Polio
2
Specific Hazards
1
Natural Hazards
1
Conflict
1
Global Health Education
1
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Anaesthesia Tutorial of the Week
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
2nd edition, June 2021
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
This document is the seventh edition of the Ministry of Health’s officially approved prescribers’ and dispensers’ guide for all levels of
healthcare. Great effort has been put into aligning the prevailing health insurance benefits package to this edition.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This module introduces the “Vaccinator’s Manual”, a guideline for vaccinators. The aim of the manual is to update EPI guidelines to include all the changes since the third edition of the Vaccinators Manual (2008)
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
